OLANZAPINE AND FLUOXETINE HYDROCHLORIDE
FLUOXETINE HYDROCHLORIDE; OLANZAPINE
Approval overview OLANZAPINE AND FLUOXETINE HYDROCHLORIDE is listed in Drugs@FDA under application 078901 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient FLUOXETINE HYDROCHLORIDE; OLANZAPINE Form and strength CAPSULE;ORAL - EQ 50MG BASE;EQ 6MG BASE Sponsor EPIC PHARMA LLC Submission history Latest submission status date: 2026-02-06 00:00:00.
Structured Monograph
Clinical summary
Approval overview OLANZAPINE AND FLUOXETINE HYDROCHLORIDE is listed in Drugs@FDA under application 078901 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient FLUOXETINE HYDROCHLORIDE; OLANZAPINE Form and strength CAPSULE;ORAL - EQ 50MG BASE;EQ 6MG BASE Sponsor EPIC PHARMA LLC Submission history Latest submission status date: 2026-02-06 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.